Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 37Neoplasms 3Neoplasm Metastasis 3Breast Diseases 3Neoplasms by Site 2Triple Negative Breast Neoplasms 1Skin Diseases 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Breast Neoplasms, Male 1Breast Neoplasm Female 1Breast Cancer Female 1Advanced Breast Carcinoma 1

Interventions

Paclitaxel 2Letrozole 2Carboplatin 2Vorinostat 1Trastuzumab 1Taxes 1Radiotherapy 1Gonadotropin-Releasing Hormone 1Fulvestrant 1Doxorubicin 1Docetaxel 1Cyclophosphamide 1Cisplatin 1Anastrozole 1Alpelisib 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Ductal, Breast × Anastrozole × Clear all
NCT01953588 2026-01-22

Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting
1,473 enrolled
Breast

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡